Adaptive Biotechnologies Corp (NASDAQ:ADPT) has a beta value of 1.78 and has seen 1.02 million shares traded in the last trading session. The company, currently valued at $1.41B, closed the last trade at $9.29 per share which meant it lost -$0.22 on the day or -2.31% during that session. The ADPT stock price is -10.66% off its 52-week high price of $10.28 and 67.81% above the 52-week low of $2.99.
The consensus among analysts is that Adaptive Biotechnologies Corp (ADPT) is Hold stock at the moment, with a recommendation rating of 1.25. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 6 out of 11 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight.
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
Sporting -2.31% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ADPT stock price touched $9.29 or saw a rise of 5.3%. Year-to-date, Adaptive Biotechnologies Corp shares have moved 54.96%, while the 5-day performance has seen it change 5.45%. Over the past 30 days, the shares of Adaptive Biotechnologies Corp (NASDAQ:ADPT) have changed 17.00%.
Wall Street analysts have a consensus price target for the stock at $14, which means that the shares’ value could jump 33.64% from current levels. The projected low price target is $5.0 while the price target rests at a high of $18.0. In that case, then, we find that the current price level is -93.76% off the targeted high while a plunge would see the stock lose 46.18% from current levels.
Adaptive Biotechnologies Corp (ADPT) estimates and forecasts
The company’s shares have gained 65.01% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -1.51% over the past 5 years. Earnings growth for 2025 is a modest 22.63% while over the next 5 years, the company’s earnings are expected to increase by 29.40%.
ADPT Dividends
Adaptive Biotechnologies Corp is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s Major holders
The top two institutional holders are VIKING GLOBAL INVESTORS LP with over 29.99 million shares worth more than $108.58 million. As of 2024-06-30, VIKING GLOBAL INVESTORS LP held 20.3466% of shares outstanding.
The other major institutional holder is RUBRIC CAPITAL MANAGEMENT LP, with the holding of over 14.0 million shares as of 2024-06-30. The firm’s total holdings are worth over $50.68 million and represent 9.4971% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are ARK ETF Trust-ARK Genomic Revolution ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Apr 30, 2025 , the former fund manager holds about 3.92% shares in the company for having 5.96 shares of worth $55.33 million while later fund manager owns 4.2 shares of worth $39.0 million as of Dec 31, 2024 , which makes it owner of about 2.76% of company’s outstanding stock.
